Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
GlobeNewswire
- ATH434-201 Trial on Track to Complete in November 2024 –
- Top-Line Data Expected in January 2025..